Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
129.7 EUR | -0.12% | +0.15% | +38.29% |
Jul. 16 | Novo Nordisk's Main Owner Leads $100 Million Financing of Biotech Firm Asceneuron | DJ |
Jul. 16 | Novo owner backs Swiss biotech Asceneuron in $100 million round | RE |
Filters
- Stock Market
- Equities
- NOVO B Stock
- NOV Stock
- News Novo Nordisk A/S